...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: a bit more volume and a bit higher

Just so odd to me that someone is selling at $0.60USD when rumors are out there for $20USD that could happen in a couple months.  Granted we've heard this before and we are still here several years later ;)

Share
New Message
Please login to post a reply